The price action shows TXN has already experienced a massive parabolic run from lows near $154 in November 2025 to a recent high of $332 in late June 2026, with the current price of $277.72 sitting well off the peak but still elevated after a volatile consolidation period; while there is some short-term stabilization, this does not represent an ideal dip-buying entry for a swing trade as momentum appears to have cooled. Fundamentally the company remains solid with strong ROE of 35.8%, high gross and net margins, a healthy current ratio, and a decent dividend, yet revenue growth has been negative over three years and the P/E of 42.8 signals the stock is not cheap relative to earnings. Key risks over the next 2-12 weeks include potential semiconductor sector rotation, high beta of 1.33 amplifying any market pullback, and the possibility that recent rally hype (analyst $1T market-cap targets and positive guidance beats) has already been priced in, leaving limited fresh catalysts. Overall this is not a compelling swing setup at current levels with estimated upside of only 5-10% at best before resistance, making it better to wait for a deeper pullback.

TXN is currently trading at $277.72, which represents a 52-week high and is significantly elevated from the $157.80 low seen in late October 2025, leaving limited room for near-term upside in a 2-12 week swing trade window. The stock has already experienced a massive rally from ~$186 in March 2026 to current levels, suggesting the easy gains have been captured and the risk/reward is now unfavorable for a swing trader seeking 10-20%+ returns. Fundamental concerns include a high P/E of 42.8x (expensive relative to historical semiconductor valuations), negative 3-year revenue growth of -4.1%, and a P/B ratio of 9.69x indicating stretched valuation; while ROE and margins are strong, they don't justify entry at current levels for a short-term trade. Key risks on the 2-12 week horizon include semiconductor cyclicality, potential profit-taking after the strong rally, geopolitical tensions affecting chip exports, and macro headwinds—combined with the stock already near resistance levels, the risk of a 5-10% pullback is material, making this an unfavorable risk/reward setup for swing trading at current prices.

Price action: TXN is trading around 277 after pulling back from a July 2026 high near 332, with a potential near-term support zone around 270–275. A close above the mid-280s could confirm renewed upside momentum toward 300+ in the near term, making 2–12 week upside plausible if the stock resumes its uptrend. Fundamental health: TXN shows strong profitability and balance-sheet strength (ROE 35.8%, net margin 31.1%, gross margin 58.3%, current ratio 4.86), supporting sustainable cash flow and potential to weather semiconductor cyclicality. Key risks: the semiconductor cycle remains sensitive to macro demand and client softness; valuation is elevated (P/E ~42.8, P/B ~9.7), so a disappointing macro read or guidance could push the stock back toward 250–265 levels; competitive dynamics (e.g., AMD) and any negative news could cap upside. Final verdict with upside: if the near-term momentum returns, a move to ~320–340 in the next 2–12 weeks offers roughly 15–23% upside from 277, with a reasonable risk of a 10–15% pullback if market conditions worsen; consider a tight stop around 265–270 to manage risk.

Texas Instruments is currently exhibiting significant technical weakness, having broken below its recent consolidation range and failing to hold the $280 support level. While the company maintains strong fundamental health with high margins and a solid balance sheet, the current P/E ratio of 42.8 is historically elevated, suggesting that much of the recent growth is already priced in. The stock is currently in a downtrend on the weekly timeframe, and the lack of a clear reversal pattern makes the current entry point risky for a short-term swing trade. Given the volatility in the semiconductor sector and the potential for further profit-taking after the massive rally earlier this year, I see limited upside potential in the 2-12 week horizon compared to the downside risk of a retest of the $250 support level.